This video has been archived.

The role of hsTn in assessing patient risks following cardiac surgery: new insights for improved care

604 views

Levels of troponin currently recommended to define clinically important periprocedural myocardial injury may not be appropriate for high sensitivity troponin assays; definitions should be re-evaluated.

There is a need for further validation in the cardiac surgery population, further research in those undergoing percutaneous coronary intervention, and to evaluate new evidence of ischemia in conjunction with current-generation troponin assays.

Watch this educational video from Abbott to find out more.


Speakers

  1. User Dr. Andre Lamy uploaded avatar

    Dr. Andre Lamy

    Speaker

    Dr. Andre Lamy is a cardiac surgeon at the Hamilton Health Sciences. He is a Professor in the...

  2. User Dr. Peter Kavsak uploaded avatar

    Dr. Peter Kavsak

    Speaker

    Dr. Kavsak is a Professor in the Department of Pathology and Molecular Medicine at McMaster...

  3. User Dr. Philip J. Devereaux uploaded avatar

    Dr. Philip J. Devereaux

    Speaker

    Dr. Devereaux obtained his MD from McMaster University.  After medical school he completed a...

Join the conversation

to comment